CEVEC Pharmaceuticals GmbH Company Profile

18:09 EST 20th November 2017 | BioPortfolio

"CEVECs business is the development of an innovative platform technology for the production of biopharmaceuticals in human cell lines. Using this proprietary process technology CEVEC has world wide USP for the use of human amnion cell lines (CAP-Cells) as expression system, which provide new opportunities for the production of antibodies, enzymes and growth factors"



News Articles [645 Associated News Articles listed on BioPortfolio]

Cevec Pharmaceuticals GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26072017] Prices from USD $250

SummaryCevec Pharmaceuticals GmbH Cevec is a healthcare products company that offers production of biopharmaceuticals. The company produces recombinant glycoproteins and gene therapy vectors. It utili...

Patent granted to CAP-Go technology for recombinant glycoproteins

CEVEC Pharmaceuticals has been granted a patent for its expression technology CAP-Go, strengthening the company’s position in producing recombinant proteins with tailor-made glycosylation.

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

MerLion Pharmaceuticals GmbH And Awarded DTRA Grant To Explore The Use Of Finafloxacin Against Biological Threat Agents

  Life Sciences Jobs   ...

Cosmos Holdings Signs Letter Of Intent To Acquire CC Pharma GmbH A Leading Re-Importer Of EU Pharmaceuticals To Germany

  Life Sciences Jobs   ...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

Jazz Pharmaceuticals to Use XL-Protein’s Technology Platform to Develop Long-Acting Asparaginase Product Candidates

DUBLIN, July 26, 2017 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has entered into a license agreement with XL-protein GmbH (“XLp”) for the rights ...

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

DIC in Decompensated Cirrhosis caused by Prothrombin Complex Concentrate and Recombinant Activated Factor VII: A Word of Caution.

We would like to respond to Scott et al. and the accompanying editorial.(1,2) Concentrated factor products like recombinant activated factor VII (NovoSeven(®) , Novo Nordisk Pharmaceuticals Inc.) an...

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Clinical Trials [243 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction

An open label, randomized controlled study in a Norwegian population with meibomian gland dysfunction. Patients will be randomized to one of two groups: THERA°PEARL Eye Mask (Bausch & Lom...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1803 Associated Companies listed on BioPortfolio]

CEVEC Pharmaceuticals GmbH

"CEVECs business is the development of an innovative platform technology for the production of biopharmaceuticals in human cell lines. Using this proprietary process technology CEVEC has world wide US...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Merz Pharmaceuticals GmbH and DiaGenic ASA

Merz Pharmaceuticals researches, develops, produces and distributes innovative pharmaceutical products in the areas of neurology and psychiatry as well as in aesthetic dermatology and metabolism. ...

Boehringer Ingelheim Pharmaceuticals, Inc

Boehringer Ingelheim Corporation is the U.S. member of the Boehringer Ingelheim worldwide group of companies dedicated to the discovery, development, manufacture and marketing of innovative human and ...

More Information about "CEVEC Pharmaceuticals GmbH" on BioPortfolio

We have published hundreds of CEVEC Pharmaceuticals GmbH news stories on BioPortfolio along with dozens of CEVEC Pharmaceuticals GmbH Clinical Trials and PubMed Articles about CEVEC Pharmaceuticals GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CEVEC Pharmaceuticals GmbH Companies in our database. You can also find out about relevant CEVEC Pharmaceuticals GmbH Drugs and Medications on this site too.

Quick Search

Relevant Topic

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Corporate Database Quicklinks

Searches Linking to this Company Record